Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M233Revenue $M27.2Net Margin (%)96.2Altman Z-Score-0.4
Enterprise Value $M100EPS $1.6Operating Margin %-175.6Piotroski F-Score4
P/E(ttm)6.0Beneish M-Score-1.2Pre-tax Margin (%)-211.9Higher ROA y-yY
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio5.7Cash flow > EarningsN
Price/Sales7.25-y EBITDA Growth Rate %--Current Ratio6.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-188.9ROA % (ttm)10.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)22.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.8ROIC % (ttm)-82.7Gross Margin Increase y-yN

Gurus Latest Trades with ZGNX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ZGNX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ZGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-31view
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-31view
TANNENBAUM RENEE PDirector 2015-12-03Buy5,000$15.4-38.44view
HAWLEY ROGERDirector 2015-06-16Buy6,250$12.72-25.47view
HAWLEY ROGERCEO 2015-03-16Buy17,500$10.48-9.54view
GARNER CAM LDirector 2014-06-13Buy3,750$13.28-28.61view
Shively Richard ScottChief Commercial Officer 2014-06-03Sell2,404$16.8-43.57view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2014-06-03Sell2,404$16.8-43.57view
HAWLEY ROGERCEO 2014-06-03Sell3,135$16.8-43.57view
FARR STEPHEN JPresident and COO 2014-06-03Sell2,613$16.8-43.57view

Quarterly/Annual Reports about ZGNX:

News about ZGNX:

Articles On GuruFocus.com
Analysts Weigh in on Zogenix in Light of Selling Zohydro Mar 12 2015 
Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB Dec 24 2012 
(ZGNX) CEO Roger Hawley buys 10,000 Shares Dec 06 2010 

More From Other Websites
ZOGENIX, INC. Files SEC form 8-K, Other Events May 05 2016
8:05 am Zogenix announces new data on ZX008 (low-dose fenfluramine) as an adjunctive therapy for... May 05 2016
Zogenix Announces New Efficacy and Safety Data on ZX008 for Treatment of Seizures in Dravet Syndrome May 05 2016
Zogenix to Release First Quarter 2016 Financial Results and Host Conference Call and Webcast on May... May 03 2016
Zogenix to Release First Quarter 2016 Financial Results and Host Conference Call and Webcast on May... May 03 2016
New Data on Zogenix's ZX008 for Dravet Syndrome to be Presented at 14th International Child... Apr 21 2016
New Data on Zogenix's ZX008 for Dravet Syndrome to be Presented at 14th International Child... Apr 21 2016
ZOGENIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 20 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of... Apr 07 2016
ETF’s with exposure to Zogenix, Inc. : March 25, 2016 Mar 25 2016
Zogenix, Inc. :ZGNX-US: Earnings Analysis: 2015 By the Numbers Mar 21 2016
ZOGENIX, INC. Financials Mar 18 2016
Zogenix, Inc.: Strong price momentum but will it sustain? Mar 15 2016
ZOGENIX, INC. Files SEC form 10-K, Annual Report Mar 15 2016
Zogenix reports 4Q loss Mar 10 2016
Zogenix reports 4Q loss Mar 10 2016
ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 10 2016
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results Mar 10 2016
Q4 2015 Zogenix Inc Earnings Release - After Market Close Mar 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)